Who owns MOLECULIN BIOTECH INC COM?
- CUSIP Number: 60855d309
Tip: Access positions for across all investors
Analyze quarterly positions in Moleculin Biotech with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Moleculin Biotech stock
Who bought or sold MOLECULIN BIOTECH INC COM this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Hrt Financial | 115k | $61k | 100% | Sep 2025 |
|
| Ieq Capital | 36k | $19k | 100% | Sep 2025 |
|
| Rockefeller Capital Management | 15k | $7.7k | 100% | Sep 2025 |
|
| BlackRock | 12k | $6.6k | 0% | Sep 2025 |
|
| Moors & Cabot | 10k | $5.3k | 100% | Sep 2025 |
|
| Tower Research Capital | 8.4k | $4.4k | 114% | Sep 2025 |
|
| Newbridge Financial Services Group | 2.9k | $1.5k | 0% | Sep 2025 |
|
| SBI Securities | 746.00 | $395.007000 | 0% | Sep 2025 |
|
| Advisor Group Holdings | 43.00 | $19.999300 | 0% | Sep 2025 |
|
| Royal Bank of Canada | 1.00 | $0 | 0% | Sep 2025 |
|
Who sold out of Moleculin Biotech?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Vanguard Group | Sep 2025 | 240k | $127k |
| Geode Capital Management | Sep 2025 | 208k | $110k |
| XTX Topco | Jun 2025 | 74k | $22k |
| Virtu Financial | Jun 2025 | 59k | $18k |
| LPL Financial | Sep 2025 | 58k | $31k |
| Verus Capital Partners | Jun 2025 | 43k | $13k |
| Wealth Dimensions Group | Sep 2025 | 20k | $11k |
| Cambridge Investment Research Advisors | Sep 2025 | 13k | $7.0k |
| Goldman Sachs Group | Sep 2025 | 13k | $6.8k |
| Branch Banking & Trust Company | Sep 2025 | 11k | $5.6k |
| Ethos Financial Group | Sep 2025 | 10k | $5.3k |
| UBS Group | Sep 2025 | 4.0k | $2.1k |
| Bogart Wealth | Sep 2025 | 300.00 | $159.000000 |
| CVA Family Office | Sep 2025 | 34.00 | $17.999600 |
| North Star Investment Management | Sep 2025 | 17.00 | $8.999800 |
| Nbc Securities | Sep 2025 | 14.00 | $7.000000 |